An interventional study of Coping with asthma through life management program and Waitlist Control (CALM) in Asthma and Stress, sponsored by Duke University. Withdrawn. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.
Sponsored by Duke University · Not applicable, Interventional, and Supportive care
The purpose of this study is to determine if the Coping with Asthma through Life Management (CALM) intervention, designed to help Black adult with asthma cope with stress, is feasible and acceptable.
Asthma medication nonadherence is a major contributor to asthma morbidity and mortality in Black adults. Black adults with asthma reported that increased psychosocial stress (e.g., perceived discrimination, job stress, caregiver burden), health-related stress (e.g., concern about asthma control), and economic stress (e.g., economic strain) were barriers to asthma medication adherence and control. The study's hypothesis is that CALM, targeting multiple stressors specifically faced by Black adults with asthma, will be feasibly implemented in a health system, will be acceptable to program participants, and will be a potentially effective intervention to improve asthma medication adherence and asthma control.
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
Browse Asthma studies →Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.
Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Group will receive intervention method
Behavioral: Coping with asthma through life management program
Participants will receive no intervention (control) during the trial. However, after the study is completed, they will have the option to receive intervention.
Behavioral: Waitlist Control (CALM)
Participants will complete surveys, learn stress coping strategies, receive asthma education information, and obtain access local community financial resources.
Participants in this group will complete surveys but will not receive the CALM intervention. Upon completing the study after 12 weeks they will be able to complete the program if they would like the resources/materials to learn healthy stress coping strategies, asthma health education, and access to financial resources.
Feasibility of Intervention Measure (FIM)
The FIM has four items and the total score ranges from 4 to 20, where a higher score indicates greater feasibility.
Time frame: 12 weeks
Acceptability of Intervention Measure (AIM)
The AIM has four items and the total score ranges from 4 to 20, where a higher score indicates greater acceptability.
Time frame: 12 Weeks
Intervention Appropriateness Measure (IAM)
The IAM has four items and the total score ranges from 4 to 20, where a higher score indicates greater appropriateness.
Time frame: 12 Weeks
Asthma Control Questionnaire (ACQ-6)
The ACQ-6 is a six-question questionnaire used to assess asthma control, focusing on symptoms and rescue medication use. Scores range from 0 to 6, with lower scores indicating better asthma control. A score of 1.5 or higher suggests poorly controlled asthma.
Time frame: 1 week
Perceived Stress Scale (PSS-10)
The PSS-10 is a 10-item questionnaire that evaluates the degree to which an individual has perceived life as unpredictable, uncontrollable, and overloading over the previous month. Scores range from 0 to 40, with higher scores indicating higher levels of perceived stress.
Time frame: 1 month
Asthma Quality of Life Questionnaire, Marks (AQLQ-M)
The AQLQ-M is a 20-item self-administered questionnaire to measure quality of life in adults with asthma. Scores range from 20 to 100, with higher scores indicating a greater negative impact of asthma.
Time frame: 2 weeks
Number of participants with an asthma exacerbation event
Time frame: 12 weeks
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is withdrawn, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke University